aspirin has been researched along with erythromycin in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (47.37) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (21.05) | 29.6817 |
| 2010's | 12 (31.58) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Balko, KM; Colby, DA; Mo, H | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gustafsson, BE; Norin, KE | 1 |
| Kandra, J; Kreiser, J; Schlossberg, D | 1 |
| Begent, RH; Lambert, HP; O'Grady, FW | 1 |
| Dam, WC; Gewurz, H; Malkinson, FD | 1 |
| Ispano, M; Luraghi, MT; Ortolani, C; Pastorello, E; Qualizza, RM; Villa, AM; Zanussi, C | 1 |
| Belhaj, MS; Bharija, SC; Kanwar, AJ | 1 |
| Koegel, L | 1 |
| Brown, RD; Henley, CM; Kupetz, S; Penny, JE | 1 |
| Amblard, P; Bastrenta, F; Beani, JC; Gautron, R; Harrouch, L; Jardon, P; Reymond, JL | 1 |
| Cohen, JL; Cohen, SN | 1 |
| Jackson, RA; Smith, MC | 1 |
| Malone, HF; Spiers, AS | 1 |
| D'Arcy, PF | 1 |
| D'Apuzzo, V; Fritz, ME; Giambonini, S; Jenni, R | 1 |
| Barre, J; Campos, H; d'Athis, P; Prandota, J; Tillement, JP | 1 |
| Planas, J; Torralba, A; Vinardell, P | 1 |
| Millar, J | 1 |
| BIGHAM, RS; JONES, PN; MANNING, PR | 1 |
| EWALD, RW; ROTHSCHILD, HJ; SCHROEDER, WC; SCHUBART, AF; TUERK, JD | 1 |
| Abroug, S; Ajmi, H; Ayeche, H; Boujaafar, N; Chemli, J; Harbi, A; Hassayoun, S; Ketata, S; Zouari, N | 1 |
| Bandyopadhyay, R; Basak, R | 1 |
2 review(s) available for aspirin and erythromycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Link between functional and morphological changes in the inner ear--functional changes produced by ototoxic agents and their interactions.
Topics: Acetylcysteine; Adult; Aminoglycosides; Aminooxyacetic Acid; Anesthetics; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Aspirin; Child; Chloramphenicol; Cochlea; Cochlear Microphonic Potentials; Diuretics; Drug Synergism; Erythromycin; Evoked Potentials, Auditory; Glycerol; Guinea Pigs; Hair Cells, Auditory; Hearing Loss, Sensorineural; Humans; Labyrinth Diseases; Noise; Otitis Media; Rats; Stria Vascularis | 1985 |
36 other study(ies) available for aspirin and erythromycin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A practical deuterium-free NMR method for the rapid determination of 1-octanol/water partition coefficients of pharmaceutical agents.
Topics: 1-Octanol; Magnetic Resonance Spectroscopy; Pharmaceutical Preparations; Water | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Development of germfree animal characteristics in conventional rats in antibiotics.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aspirin; Bacitracin; Bile Pigments; Cholestanol; Clofibrate; Colistin; Erythromycin; Feces; Ferrous Compounds; Germ-Free Life; Intestines; Kanamycin; Male; Metronidazole; Neomycin; Oxytetracycline; Penicillin G; Rats; Sorbitol; Sulfathiazoles; Tetracycline | 1977 |
Possible Kawasaki disease in a 20-year-old woman.
Topics: Adult; Age Factors; Aspirin; Diagnosis, Differential; Erythromycin; Female; Humans; Lymphatic Diseases; Mucocutaneous Lymph Node Syndrome; Staphylococcal Infections; Streptococcal Infections | 1979 |
Sensible prescribing. III. Acute otitis media and sore throat.
Topics: Amphotericin B; Ampicillin; Anti-Bacterial Agents; Aspirin; Cephalexin; Drug Prescriptions; Erythromycin; Haemophilus influenzae; Humans; Metronidazole; Nystatin; Otitis Media; Penicillins; Pharyngitis; Staphylococcus; Streptococcus pyogenes | 1975 |
The effect of common antibiotics on lymphocyte transformation.
Topics: Aspirin; Dose-Response Relationship, Drug; Erythromycin; Humans; Lectins; Lymphocyte Activation; Penicillins; Tetracycline | 1975 |
[Occurrence of drug reactions].
Topics: Acetaminophen; Adult; Anaphylaxis; Angioedema; Aspirin; Asthma; Drug Hypersensitivity; Emergencies; Erythromycin; Female; Glafenine; Humans; Indomethacin; Italy; Male; Penicillins; Propionates; Prospective Studies; Pyridazines; Rifampin; Urticaria; Vitamin B Complex | 1986 |
Fixed drug eruptions in children: a series of 23 cases with provocative tests.
Topics: Age Factors; Ampicillin; Aspirin; Butylscopolammonium Bromide; Child; Child, Preschool; Drug Hypersensitivity; Erythromycin; Female; Humans; Infant; Male; Skin Tests | 1986 |
Ototoxicity: a contemporary review of aminoglycosides, loop diuretics, acetylsalicylic acid, quinine, erythromycin, and cisplatinum.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Aspirin; Auditory Threshold; Cisplatin; Diuretics; Dose-Response Relationship, Drug; Ear, Inner; Erythromycin; Female; Hearing Loss, Sensorineural; Humans; Male; Middle Aged; Quinine; Vestibule, Labyrinth; Vestibulocochlear Nerve | 1985 |
Screening for drug photosensitization activity by measuring the variations in oxygen consumption of Bacillus subtilis.
Topics: Aspirin; Bacillus subtilis; Benzoyl Peroxide; Chlorpromazine; Erythromycin; Fluorouracil; Light; Methoxsalen; Oxygen Consumption; Patch Tests; Photosensitivity Disorders; Tretinoin | 1985 |
Pharmacotherapeutics. Review and commentary.
Topics: Acetaminophen; Acetanilides; Amphetamine; Ampicillin; Analgesics; Anti-Bacterial Agents; Aspirin; Child; Child Behavior Disorders; Child, Preschool; Chloramphenicol; Costs and Cost Analysis; Drug Therapy; Erythromycin; Humans; Methylphenidate; Pediatrics; Penicillins; Tetracycline | 1974 |
Relations between price and quality in community pharmacy.
Topics: Aspirin; Community Pharmacy Services; Contraceptives, Oral; Drug Interactions; Drug Prescriptions; Erythromycin; Fees, Pharmaceutical; Health Education; Mississippi; Pharmacists; Quality of Health Care; Thermometers; Warfarin | 1974 |
Serum hexosamine levels in normal subjects.
Topics: Adolescent; Adult; Aspirin; Erythromycin; Heparin; Hexosamines; Humans; Kanamycin; Salicylates | 1966 |
Early reports on drug interactions.
Topics: Acetaminophen; Amiodarone; Apazone; Aspirin; Carbamazepine; Chlordiazepoxide; Cimetidine; Coumarins; Drug Interactions; Erythromycin; Ethanol; Furosemide; Gentamicins; Humans; Levodopa; Lidocaine; Phenytoin; Prenylamine; Quinidine | 1983 |
[The mucocutaneous lymph node syndrome (Kawasaki syndrome). A case with gallbladder hydrops and coronary artery aneurysm].
Topics: Aneurysm; Aspirin; Child, Preschool; Coronary Disease; Edema; Erythromycin; Exanthema; Gallbladder Diseases; Humans; Lymphatic Diseases; Male; Mucocutaneous Lymph Node Syndrome; Steroids | 1981 |
Binding of erythromycin base to human plasma proteins.
Topics: Aspirin; Bilirubin; Blood Proteins; Erythromycin; Furosemide; Humans; Hydrogen-Ion Concentration; Orosomucoid; Phenylbutazone; Protein Binding; Serum Albumin; Temperature; Warfarin | 1980 |
Inhibition of erythromycin lactobionate-induced writhing by analgesic drugs.
Topics: Analgesics; Animals; Aspirin; Codeine; Dextropropoxyphene; Erythromycin; Indomethacin; Male; Mice; Morphine; Nalorphine; Naloxone; Pain; Phenylbutazone | 1980 |
Excipient E110: a cause for complaint?
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross Reactions; Drug Hypersensitivity; Drug Information Services; Erythromycin; Excipients; Humans; Male; Middle Aged | 2000 |
Use of antibiotics in nonbacterial respiratory infections.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Aspirin; Dermatologic Agents; Erythromycin; Humans; Oxytetracycline; Respiratory System; Respiratory Tract Diseases; Respiratory Tract Infections | 1953 |
EFFECT OF PENICILLIN TREATMENT ON SERUM COMPLEMENT LEVELS IN ACUTE RHEUMATIC FEVER.
Topics: Aspirin; Complement System Proteins; Erythromycin; Humans; Penicillins; Rheumatic Fever; Streptococcal Infections; Sulfadiazine | 1963 |
[Kawasaki disease and Mycoplasma pneumoniae infection].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Coronary Vessels; Erythromycin; Female; Heart Aneurysm; Humans; Immunoglobulin G; Immunoglobulin M; Immunoglobulins, Intravenous; Mucocutaneous Lymph Node Syndrome; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Ultrasonography; Vasodilation | 2010 |
Encapsulation of hydrophobic drugs in Pluronic F127 micelles: effects of drug hydrophobicity, solution temperature, and pH.
Topics: Aspirin; Erythromycin; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Ibuprofen; Micelles; Molecular Structure; Particle Size; Poloxamer; Solutions; Surface Properties; Temperature | 2013 |